BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23861426)

  • 1. The next step in controlling HBV in China.
    Xu Y; Liu H; Wang Y; Hao R; Li Z; Song H
    BMJ; 2013 Jul; 347():f4503. PubMed ID: 23861426
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B immunisation leads to the decline of hepatitis B virus prevalence in Gansu province, China.
    Liu C; Li H; Gao L; Li F; Liang X; Yang K
    Aust N Z J Public Health; 2011 Feb; 35(1):91-2. PubMed ID: 21299712
    [No Abstract]   [Full Text] [Related]  

  • 3. The China GAVI Project.
    Berkley S
    Vaccine; 2013 Dec; 31 Suppl 9():J3-4. PubMed ID: 24331018
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
    Wang WL; Shu ZJ; Zhou LX; Zhao YR
    Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and prevention of hepatitis B virus infection in China.
    Lu FM; Li T; Liu S; Zhuang H
    J Viral Hepat; 2010 Mar; 17 Suppl 1():4-9. PubMed ID: 20586928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
    Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The analysis of "a" dominant mutation of hepatitis B virus in community-based population of Shandong Province, China].
    Zhang L; Yan BY; Ji F; Li MS; Song LZ; Xu AQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):424-6. PubMed ID: 21604565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
    Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS
    J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.
    Luo Z; Li L; Ruan B
    Int J Infect Dis; 2012 Feb; 16(2):e82-8. PubMed ID: 22178658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 11. Estimating the impact of vaccination using age-time-dependent incidence rates of hepatitis B.
    Hens N; Aerts M; Shkedy Z; Kung'u Kimani P; Kojouhorova M; van Damme P; Beutels P
    Epidemiol Infect; 2008 Mar; 136(3):341-51. PubMed ID: 17506920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination.
    Papaevangelou V; Hadjichristodoulou C; Cassimos DC; Pantelaki K; Tzivaras A; Hatzimichael A; Theodoridou M
    Infection; 2008 Mar; 36(2):135-9. PubMed ID: 18231718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foreword. Hepatitis B and the impact of immunization in China and the WHO Western Pacific Region.
    Yu W
    Vaccine; 2013 Dec; 31 Suppl 9():J2. PubMed ID: 24331016
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization.
    Hipgrave DB; Nguyen TV; Vu MH; Hoang TL; Do TD; Tran NT; Jolley D; Maynard JE; Biggs BA
    Am J Trop Med Hyg; 2003 Sep; 69(3):288-94. PubMed ID: 14628946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization.
    Hsu HM; Lu CF; Lee SC; Lin SR; Chen DS
    J Infect Dis; 1999 Feb; 179(2):367-70. PubMed ID: 9878020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B Virus Update.
    Hassanein TI
    Clin Liver Dis; 2019 Aug; 23(3):xiii-xiv. PubMed ID: 31266628
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program.
    Gîlca V; Duval B; Boulianne N; Dion R; De Serres G
    Pediatr Infect Dis J; 2006 Apr; 25(4):372-4. PubMed ID: 16567995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B Vaccine in national immunization schedule: a preventive step in India.
    Verma R; Khanna P; Prinja S; Rajput M; Chawla S; Bairwa M
    Hum Vaccin; 2011 Dec; 7(12):1387-8. PubMed ID: 22134433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine.
    Poland GA; Jacobson RM
    N Engl J Med; 2004 Dec; 351(27):2832-8. PubMed ID: 15625334
    [No Abstract]   [Full Text] [Related]  

  • 20. Achieving ultimate control of hepatitis B infection in China: progress and challenges.
    Jia JD; Yao GB
    J Viral Hepat; 2010 Mar; 17 Suppl 1():2-3. PubMed ID: 20586927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.